Journal article
Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury
Abstract
IMPORTANCE: Calcium-channel blockers are metabolized by the cytochrome P450 3A4 (CYP3A4; EC 1.14.13.97) enzyme. Blood concentrations of these drugs may rise to harmful levels when CYP3A4 activity is inhibited. Clarithromycin is an inhibitor of CYP3A4 and azithromycin is not, which makes comparisons between these 2 macrolide antibiotics useful in assessing clinically important drug interactions.
OBJECTIVE: To characterize the risk of acute …
Authors
Gandhi S; Fleet JL; Bailey DG; McArthur E; Wald R; Rehman F; Garg AX
Journal
JAMA: The Journal of the American Medical Association, Vol. 310, No. 23, pp. 2544–2553
Publisher
American Medical Association (AMA)
Publication Date
December 18, 2013
DOI
10.1001/jama.2013.282426
ISSN
0098-7484